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Dose reconstruction through deconvolution of dosimeter responses
Technical Note: Reconstruction of physical and biological dose distributions
of carbon-ion beam through deconvolution of longitudinal dosimeter
responses
Nobuyuki Kanematsu,a) Taku Inaniwa, Shunsuke Yonai, and Hideyuki Mizuno
National Institute of Radiological Sciences, QST; 4-9-1 Anagawa, Inage-ku, Chiba 263-8555,
Japan
(Dated: 28 September 2018)
Purpose: This is a theoretical simulation study for proof of concept of radiochromic film dosimetry to
measure physical and biological doses without plan-based quenching correction for patient-specific quality
assurance of carbon-ion radiotherapy.
Methods: We took a layer-stacking carbon-ion beam comprised of range-shifted beamlets. The dosimeter
response was simulated according to an experimental quenching model. The beam model followed a treat-
ment planning system. The beam was decomposed into finely arranged beamlets with weights estimated by
deconvolution of longitudinal dosimeter responses. The distributions of physical and biological doses were
reconstructed from the estimated weights, and were compared with the plan. We also evaluated the sensitivity
to measurement errors and to erratic delivery with an undelivered beamlet.
Results: The reconstructed physical and biological doses accurately reproduced the simulated delivery with
errors approximately corresponding to the measurement errors. The erratic beam delivery was easily de-
tectable by comparison of biological dose distribution to the plan.
Conclusions: We have developed a method to measure physical and biological doses by longitudinal dosime-
try of quenched response without using plan data. The method only involves a general optimization algorithm,
a radiobiology model, and experimental beamlet data, and requires no extra corrections. Theoretically, this
approach is applicable to various dosimeters and to proton and ion beams of any delivery method, regardless
of quenching or biological effectiveness.
PACS numbers: 87.52.Ln, 87.53.Pb, 87.53.Xd
Keywords: particle therapy, patient-specific quality assurance, radiochromic film dosimetry, high-LET radia-
tion, quenching effects
I. INTRODUCTION
In state-of-the-art radiotherapy (RT), highly complex
beams are delivered for optimum treatment of individual
patients, for which quality assurance (QA) must always
be secured. In patient-specific QA, the quality of treat-
ment beams is verified by dose comparison between mea-
surements and calculations of a QA plan with a phantom
in place of the patient before treatment.1 On such occa-
sions, self-developing radiochromic films (RCF), such as
Gafchromic
TM
EBT3 (Ashland Inc., Bridgewater, NJ),
are conveniently used for high-resolution planar dosime-
try.
For proton and ion beams, however, RCF dosime-
try suffers from quenching, namely sensitivity reduction
with linear energy transfer (LET) of ionizing particles.2,3
The quenching effect is especially unfavorable in carbon-
ion RT,4 which utilizes its high-LET Bragg peak to en-
hance the relative biological effectiveness (RBE) for tu-
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mor cells.5 The dependence of RCF sensitivity on dose-
averaged LET has been evaluated experimentally with
clinical carbon-ion beams for potential application to
quenching correction in dosimetry.6 Such a correction
will require prior knowledge of the spatial LET distribu-
tion, which is not generally measurable in a clinical setup
and should be obtained from a treatment plan somehow.7
The involvement of plan-based correction poses a ques-
tion for the validity of dosimetric QA as an indepen-
dent verification against the plan, especially because LET
and dose, namely energy transfer and absorption, are in-
trinsically correlated. Alternatively, patient-specific QA
may be achievable by direct comparison of dosimeter re-
sponses between measurement and calculation by a con-
volution algorithm configured with a special kernel for
the response.8
In carbon-ion RT, clinical assessment of treatment
plans is generally performed with distributions of RBE-
weighted dose or biological dose, which is normally uni-
form over a spread-out Bragg peak (SOBP). In patient-
specific QA, the biological dose distribution is naturally
desired for clinical assessment. For a broad-beam de-
livery system with range modulation fixed per ridge fil-
ter, the longitudinal physical dose profiles measured with
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a multilayer ionization chamber have been successfully
converted to biological dose profiles based on the prede-
fined beam data for each modulation.9 That approach
is, however, not applicable to variable range modulation
planned specifically for each treatment with scanning or
layer-stacking beams.10,11
In this study, we propose a new dosimetric method to
measure physical and biological doses without plan-based
correction for QA of carbon-ion RT. For this purpose, we
conceptually follow the longitudinal RCF dosimetry pro-
posed for proton beams,12 apply the deconvolution-and-
reconstruction approach proposed for in vivo dosimetry
with positron emission tomography after proton RT,13
and undertake a proof of concept through theoretical sim-
ulation.
II. MATERIALS AND METHODS
A. Simulation apparatus
1. Carbon-ion beam
We took a broad carbon-ion beam of 290 MeV per nu-
cleon moderated by a Gaussian ripple filter (σ = 1.8 mm)
having an available beam range of 154.2 mm in water,11
for an elementary beam or beamlet. Figure 1 shows dose
D0, dose-averaged LET L0, and dose-averaged radiosen-
sitivity parameters α0 and
√
β0 of the linear-quadratic
(LQ) model as functions of depth, for the basis beamlet,
namely the one without range shifting. A beam mod-
ulated by layer stacking is comprised of range-shifted
beamlets in dose,
DM(d) =
∑
i
wiDi(d) with (1)
Di(d) = D0(d+ si), (2)
where d is the depth in water and si and wi are the range
shift and the weight of beamlet i.
2. Dosimeter response
To simulate RCF responses, we applied an empir-
ical model by Yonai et al.6 In their dosimetry with
Gafchromic
TM
EBT3 calibrated for a 6-MV x ray, the
relative efficiency ǫ of dose response to carbon-ion beams
was formulated as a function of dose-averaged LET L,
ǫ(L) = 1− 0.0732
( µm
keV
L− 8.65
)0.388
, (3)
for L > 8.65 keV/µm or ǫ = 1 otherwise. Accord-
ingly, dose D would be measured as dosimeter response
F = ǫD. Assuming the additivity, we can decompose a
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FIG. 1. (a) Relative dose D0 with modeled RCF response F0,
(b) dose-averaged LET L0, and (c) dose-averaged LQ param-
eters α0 and
√
β0 for a human salivary gland tumor cell line
as functions of depth in water d for a ripple-filtered carbon-
ion beam of 290 MeV per nucleon, configured in a treatment
planning system.11
modulated beam into beamlets in the dosimeter response,
FM(d) =
∑
i
wi Fi(d) with (4)
Fi(d) = F0(d+ si) and F0 = ǫ(L0)D0, (5)
where Fi is the dosimeter response to beamlet i and
F0 is that to the basis beamlet, which is also shown in
Fig. 1(a).
3. Biological response
The radiation mixing due to the modulation was han-
dled by dose-weighted averaging of radiosensitivity pa-
rameters αi(d) = α0(d + si) and
√
βi(d) =
√
β0(d + si)
over the beamlets,14
αM =
∑
i wiDi αi
DM
(6)
√
βM =
∑
iwiDi
√
βi
DM
. (7)
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The biological dose BM, formulated as
BM =
√
α2x
4β2x
+
αMDM + βMD2M
βx
− αx
2βx
, (8)
is the dose of a reference x-ray radiation for a given sur-
vival fraction of reference cells, for which we took human
salivary gland tumor cells with x-ray sensitivity param-
eters αx = 0.331 Gy
−1 and βx = 0.0593 Gy
−2.15 The
survival fraction of the reference cells S is simply an ex-
ponential LQ function of biological dose B, with which
the biological effect is defined as
E(B) = lnS(B) = αxB + βxB
2. (9)
4. Range modulation
We arranged 32 beamlets with range shifts of 4.2 mm
to 81.7 mm at 2.5-mm intervals to form a modulated
beam having a SOBP size of 80 mm and a beam range
of 150 mm in water. With decomposing the biological
effect into beamlet contributions,
EM = αMDM + βMD
2
M =
∑
i
wiEi with (10)
Ei =
(
αi +
√
βi
√
βMDM
)
Di, (11)
we optimized the beamlet weights to give a uniform bio-
logical effect in the SOBP by convergence of multiplica-
tive recursion,16
wi :=
∑
j E
2
i (dj)E(B)∑
j E
2
i (dj)EM(dj)
wi, (12)
where dj is a SOBP sampling depth, for which we took
the peak-dose depth of each beamlet, and we prescribed
B = 4.04 Gy for 10% survival.
B. QA dosimetry simulation
1. Measurement
For the modulated beam, we simulated longitudinal
RCF dosimetry for depths from 0 mm to 200 mm sampled
at 1-mm intervals with random measurement errors of a
normal distribution, and obtained the dosimeter response
at each sampling depth dj by
Fˆj = (1 + σN rNj)FM(dj), (13)
where rNj is a random number of the standard normal
distribution and σN is a relative standard uncertainty of
the response measurement.
2. Deconvolution and reconstruction
To decompose the modulation, we newly arranged pos-
sible beamlets of range shift sˆi from 0 mm to the peak-
dose depth of the basis beamlet at 0.5-mm intervals, and
estimated their weights wˆi by convergence of multiplica-
tive recursion,
wˆi :=
∑
j F
2
i (dj) Fˆj∑
j F
2
i (dj)FR(dj)
wˆi with (14)
FR(dj) =
∑
i
wˆiFi(dj), (15)
where Fi is the dosimeter response to beamlet i and FR is
the reconstructed dosimeter response. On each recursion,
the minimum-weight beamlet was deleted if its weight
was less than 1% of the maximum, to eliminate insignif-
icant beamlets. Using the resultant beamlets, we also
reconstructed the distributions of physical dose DR and
biological dose BR, and compared them with the plan.
3. Sensitivity to errors
We evaluated the sensitivity of the dosimetry to mea-
surement errors by varying the relative standard un-
certainty of response among σN = 0%, 1%, and 2%,
which may cover the dose uniformity of ±2% specified for
EBT3 by the manufacturer. In addition, we intentionally
deleted the 16th beamlet to test the detectability of such
an erratic delivery of a corrupt plan with random errors
of σN = 1%.
III. RESULTS
Figure 2 shows the range-shift modulations delivered
and reconstructed, the dosimeter responses measured and
reconstructed, and the physical and biological doses de-
livered and reconstructed in the QA dosimetry simula-
tion. The estimated weights did not exactly reproduce
the delivered weights, even considering a factor of 5 dif-
ference in resolution. As each beamlet had mixed ranges
with a variation of a few mm by the ripple filter and nat-
ural straggling, the estimation was intrinsically limited in
range-shift resolution. Nevertheless, except at both ends
of the SOBP, the reconstructed doses accurately repro-
duced the delivered doses. In the SOBP, the dosimetric
errors approximately corresponded to the random mea-
surement errors. The erratic beam delivery with an un-
delivered beamlet was easily detectable when compared
with the plan. In these plots, the errors were more ap-
parent in biological dose than in physical dose having
inherent gradient in the SOBP.
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FIG. 2. QA dosimetry simulation for a layer-stacking beam of 150-mm range and 80-mm SOBP: (a) range-shift spectra of
beamlet weights in hMU (or beamlet peak doses in Gy) for the modulations delivered (wi, green) and estimated (wˆi, blue); (b)
dosimeter responses measured (Fj , red markers) and reconstructed (FR, solid blue), physical doses delivered (DM, green) and
reconstructed (DR, dashed blue), and biological doses delivered (BM, green) and reconstructed (BR, dotted blue); (c, d) and
(e, f) are the same as (a, b) but with random measurement error of 1% and 2%, respectively; (g, h) is the same as (c, d) but
with an undelivered beamlet and shown with planned doses (black).
IV. DISCUSSION
We have demonstrated the theoretical feasibility of QA
of layer-stacking carbon-ion RT by RCF dosimetry with-
out using plan data. The response precision of σN = 1%,
which may be consistent with the EBT3 specification,
would be sufficient for the standard QA tolerance of
2% or 3%.1 The quenching simulation based on dose-
averaged LET, originally for a carbon-ion beam of 60-mm
SOBP,6 could have been inaccurate for the ripple-filtered
beam due to differences in the LET spectrum. In reality,
however, the quenched dosimeter response to the basis
beamlet F0(d) should always be measured experimen-
tally. The assumption of additivity of RCF responses
is supported by the fact that RCF is widely used for
multifield and dynamic beam deliveries of various dose
rates.1
The dose distributions on the phantom measurement
axis can further be mapped through water-equivalent
depth onto the patient image for clinical evaluation.9 In
addition, a film naturally offers two-dimensional dosime-
try on multiple axes along the beam, and stacked films
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will offer three-dimensional dosimetry. By implement-
ing the radiobiology model that is common to treatment
planning, QA practitioners can concentrate on beam-
delivery errors. In addition, they can also measure the
biological dose in any radiobiology model by configur-
ing the dosimetry system as such, which will be useful
for the intercomparison of prescribed doses in a multi-
institutional clinical research of carbon-ion RT with in-
stitutional model variations.17
The deconvolution procedure replicates a common
SOBP optimization, and is naturally applicable also to
scanning and conventional broad beams. To resolve range
modulation, the use of a pristine Bragg peak for the ba-
sis beamlet would be ideal for its minimized range mix-
ing, but it could also worsen random errors. For energy
scanning,10 the acceleration energies, instead of range
shifts, should be resolved using the beamlets measured
individually for all energies. The present approach is also
applicable to proton and other ion beams and to many
other dosimeter types such as semiconductors, scintilla-
tors, radiochemical gels, thermoluminescence and radio-
photoluminescence dosimeters, etc., as long as they sat-
isfy the requirements for precision, dynamic range, stabil-
ity, element size and pitch, phantom perturbation, ease
of use, cost, etc. Such products will be especially useful
when the dosimetry involves systematic response varia-
tion such as quenching, or when the treatment planning
involves model-based dose correction such as RBE.18
V. CONCLUSIONS
In this proof-of-concept study, we have developed a
method to measure physical and biological doses of
carbon-ion RT by longitudinal dosimetry of quenched re-
sponse without using plan data. This method only in-
volves a general optimization algorithm, a radiobiology
model, and experimental beamlet data, and requires no
extra corrections. The dosimetric precision reflected the
intrinsic RCF performance, which may generally satisfy
QA requirements. The range mixing within each beamlet
limited the deconvolution and caused minor moderation
to the reconstructed dose distributions especially at the
ends of SOBP. Theoretically, this approach is applicable
to various dosimeters and to proton and ion beams of any
delivery method, regardless of quenching or RBE.
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